Northwestern Medicine scientists have discovered a mechanism that makes a prostate cancer-causing protein called FOXA1 more resilient, according to a recent study.
Gender-affirming hormone treatment caused cholesterol levels to increase for people designated male at birth and decrease for people designated female at birth, according to a recent study.
Prolonged contact between the mitochondria and the lysosome causes aberrant distribution of mitochondria, contributing to neuronal dysfunction in Parkinson’s disease.
Northwestern Medicine investigators are advancing the understanding of two groups of transcription factors and their role in many neurodevelopmental diseases and cancers, which is essential for developing novel therapeutic approaches.
Northwestern Medicine investigators have discovered how a particular type of immune cell exerts a dual function in cancer cells that is contingent on tumor grade.
Lakeside Discovery, LLC, the collaboration between Northwestern University and Deerfield Management, will support the laboratory of Paul DeCaen, PhD in a multi-year partnership to advance new therapies for genetically driven polycystic kidney disease.
A massive trove of information produced in a Northwestern-led study will lay the groundwork for understanding sex-related differences in health and disease for decades to come.
Stephen Miller, PhD, received the 2021 Technology Innovation and Development Award from the Society For Biomaterials for work on a nanoparticle that induces gluten tolerance in celiac disease.
Imbalanced activation of cells and previously unknown neural connections may be responsible for some motor symptoms in Parkinson’s disease and similar neurodegenerative conditions, according to two recent studies.
Inhibiting production of a key material produced by the mTOR pathway could slow tumor growth, according to a recent Northwestern Medicine study.